BiomX Inc. (PHGE) Research

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

Market snapshot

Symbol
PHGE
Price
$0.52
Day change
-5.47%
Market cap
$828.5K
P/E ratio
-0.03x
52-week range
0.361-14.706
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$38.00

Peer companies

  • Adaptimmune Therapeutics plc (ADAP)
  • BioRestorative Therapies, Inc. (BRTX)
  • Dogwood Therapeutics, Inc. (DWTX)
  • Edesa Biotech, Inc. (EDSA)
  • Ernexa Therapeutics Inc. (ERNA)
  • Immuron Limited (IMRN)
  • MapLight Therapeutics, Inc. (MPLT)
  • OSR Holdings, Inc. (OSRH)

Recent insider activity

  • Yeganeh Reuven — S-Sale (1300000 shares) on 2026-03-16
  • Yeganeh Reuven — S-Sale (2000000 shares) on 2026-03-16
  • Yeganeh Reuven — C-Conversion (530000 shares) on 2026-03-17
  • Yeganeh Reuven — C-Conversion (450000 shares) on 2026-03-16
  • Yeganeh Reuven — C-Conversion (900 shares) on 2026-03-16

Open BiomX Inc. (PHGE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.